Fact CheckerSign in

NCT06862115CompletedPhase 3

The Effect of Discontinuation of Renin Angiotensin System Inhibitors on the Perioperative Myocardial Injury in Adult Patients Undergoing Colorectal Cancer Surgery

The Effect of Discontinuation of Renin Angiotensin System Inhibitors on the Perioperative Myocardial Injury in Adult Patients Undergoing Colorectal Cancer Surgery: a Randomized Controlled Non Inferiority Study.

Source: ClinicalTrials.gov · Last updated 19 Aug 2026

Brief summary (registry, in English)

The aim of this study is to estimate the effect of discontinuation of RAS inhibitors on myocardial injury in cancer patients undergoing major abdominal surgeries.

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
182 (actual)
First submitted
1 Mar 2025
Start date
1 Mar 2025
Primary completion date
10 Aug 2026
Lead sponsor
Kasr El Aini Hospital
NCT number
NCT06862115

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 182
  • From 1 Mar 2025 to the primary completion date, 10 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Emergency surgery

Other illness

  • Recent myocardial infarction (within 3 months).
  • Any condition, which in the opinion of the treating clinician, would result in the patient being harmed by the cessation of the ACE-I and/or ARB therapy.

Other

  • Patient refusal.

Who the study is looking for

  • Age \> 18 years
  • Both sexes
  • ASA 2-3
  • Chronic hypertensive patients (\> 3 months before surgery) controlled on ACEIs or ARBs or combination therapy containing one of the RAS inhibitors.
  • Scheduled for major abdominal cancer surgery (surgery with an expected duration of \> 2 h from the surgical incision and a postoperative hospital stay of least three days).

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cairo University Hospitals
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.